ApprovalTrail

Approval · Notice of Compliance 25111 · 2021

CESAMET: Notice of Compliance 25111

Issued January 29, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
25111
Date
January 29, 2021
Company
Bausch Health, Canada Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Update the design of the labels according to the new bausch health colour

Products in this notice

BrandDINStatus today
CESAMETNot yet assigned—

Medicinal ingredients